In addition, FGF21 promotes the expression of SIRTI and PGC‐1α signaling pathways (Md 2010), which are down‐regulated in MS (Li et al. 2020; Witte et al. 2013). This evidence concerns the gene FGF21 and myeloid sarcoma.